The Lancet

Publication Venue For

• The health and wellbeing of Indigenous adolescents: a global collective for an equitable and sustainable future 2022
• Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial 2021
• Informing public health messages and strategies to raise awareness of pre-conception health: a public consultation 2021
• Patient safety: the value of the nurse 2021
• US withdrawal from WHO is unlawful and threatens global and US health and security 2020
• Global surveillance of trends in cancer survival 2000¿14 (CONCORD-3): analysis of individual records for 37?513?025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries 2018
• A personalised or procrustean approach to treating hypertension? 2017
• Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants 2017
• Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults 2017
• Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants 2016
• Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants 2016
• Lessons from the Liverpool Care Pathway-evidence is key 2014
• Addressing the disconnect between public health science and personalised health care: the potential role of cluster analysis in combination with multi-criteria decision analysis 2013
• Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: A double-blind, randomised controlled trial 2010
• Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials 2010
• Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies 2008
• Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial 2008
• Environmental tobacco smoke research published in the journal and associations with the tobacco industry 2005
• Sheffield risk and treatment table for primary prevention of coronary heart disease 1996
• Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease 1995
• Presymptomatic testing in families with Wilson's disease 1994
• Pulse oximetry in newborn babies 1994
• Home cholesterol testing 1993
• Coronary atheroma regression trials 1992
• Finnish trial of cardiovascular disease prevention 1992
• Investigation of selected patients with hypertension by the rapid-sequence intravenous urogram 1992
• Tests for renovascular disease 1992
• Tests for renovascular disease 1992
• ACE inhibitor cough: a genetic link? 1991
• FISH AND THE HEART 1989
• GIARDIA AND CRYPTOSPORIDIUM IN DRINKING WATER 1987
• INTRAUTERINE INSEMINATION 1987
• ENDOMETRIOSIS AND IVF: EFFECT OF PRIOR THERAPY 1986
• ENDOMETRIOSIS AND OVULATORY DISORDER: REDUCED FERTILISATION IN VITRO COMPARED WITH TUBAL AND UNEXPLAINED INFERTILITY 1985
• MALONALDEHYDE IN CERVICA MUCUS ASSOCIATED WITH COPPER IUD 1980
• HYPERAMMONÆMIA AND URINARY ORGANIC ACIDS 1979
• EFFECTS OF THERAPY ON PLASMA-HIGH-DENSITY-LIPOPROTEIN-CHOLESTEROL CONCENTRATION IN DIABETES MELLITUS 1978
• H.D.L.-CHOLESTEROL AND DIABETES 1978